MAGNITUDE AND TIMING OF CHANGE IN MONITORING PARAMETERS FOR TRANSTHYRETIN AMYLOIDOSIS CARDIOMYOPATHY PATIENTS TREATED AND UNTREATED WITH TAFAMIDIS

被引:0
|
作者
Shahi, Karan [1 ]
Miller, Robert Jh [1 ]
Dykstra, Steven [1 ]
Feng, Yuanchao [1 ]
Howlett, Jonathan G. [1 ]
Kassam, Shireen [1 ]
Veenhuyzen, Jan [1 ]
White, James [1 ]
Fine, Nowell Mark [1 ]
机构
[1] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1305-123
引用
收藏
页码:508 / 508
页数:1
相关论文
共 50 条
  • [41] Relationship of binding-site occupancy, transthyretin stabilisation and disease modification in patients with tafamidis-treated transthyretin amyloid cardiomyopathy
    Tess, David. A. A.
    Maurer, Tristan. S. S.
    Li, Zhenhong
    Bulawa, Christine
    Fleming, James
    Moody, Amy. T. T.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2023, 30 (02): : 208 - 219
  • [42] Modeling of Survival and Frequency of Cardiovascular-Related Hospitalization in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis
    Camille Vong
    Martin Boucher
    Steve Riley
    Lutz O. Harnisch
    American Journal of Cardiovascular Drugs, 2021, 21 : 535 - 543
  • [43] Prognostic Role Of Cardiopulmonary Exercise Testing In Wild Type Transthyretin Amyloid Cardiomyopathy Patients Treated With Tafamidis
    Dalia, Tarun
    Acharya, Prakash
    Chan, Wan-Chi
    Sauer, Andrew
    Weidling, Robert
    Fritzlen, John
    Goyal, Amandeep
    Miller, Dana
    Porter, Charles
    Shah, Zubair
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S21 - S21
  • [44] Modeling of Survival and Frequency of Cardiovascular-Related Hospitalization in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis
    Vong, Camille
    Boucher, Martin
    Riley, Steve
    Harnisch, Lutz O.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (05) : 535 - 543
  • [45] Prognostic factors associated with survival in patients with wild-type transthyretin amyloid cardiomyopathy, treated with tafamidis
    Zemljic, G.
    Frljak, S.
    Poglajen, G.
    Zorz, N.
    Cerar, A.
    Okrajsek, R.
    Bajec, T.
    Vrtovec, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 162 - 162
  • [46] Diagnosis of transthyretin amyloidosis in patients with established cardiomyopathy
    Martin-Alvarez, Esteban
    Larranaga-Moreira, Jose Maria
    Barge-Caballero, Gonzalo
    Souto-Cainzos, Borja
    Crepo-Leiro, Maria Generosa
    Barriales-Villa, Roberto
    REVISTA ESPANOLA DE CARDIOLOGIA, 2024, 77 (04): : 347 - 349
  • [47] Long-Term Effect of Tafamidis on Clinical Parameters and Prognostic Predictors in Patients With Transthyretin Amyloid Cardiomyopathy
    Kuyama, Naoto
    Izumiya, Yasuhiro
    Takashio, Seiji
    Usuku, Hiroki
    Tabira, Akihisa
    Oguni, Tetsuya
    Yamamoto, Masahiro
    Hirakawa, Kyoko
    Ishii, Masanobu
    Tabata, Noriaki
    Hoshiyama, Tadashi
    Kanazawa, Hisanori
    Hanatani, Shinsuke
    Kidoh, Masafumi
    Oda, Seitaro
    Matsuzawa, Yasushi
    Yamamoto, Eiichiro
    Hirai, Toshinori
    Ueda, Mitsuharu
    Tsujita, Kenichi
    CIRCULATION JOURNAL, 2025, 89 (04) : 421 - 431
  • [48] Effect of tafamidis on left atrial function in patients with transthyretin amyloid cardiomyopathy
    Uemura, K.
    Ichikawa, Y.
    Nagai, S.
    Takeuchi, M.
    Nishihara, Y.
    Takeuchi, K.
    Oota, E.
    Odajima, S.
    Kintsu, M.
    Todo, S.
    Fukuda, T.
    Hisamatsu, E.
    Hirata, K.
    Tanaka, H.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [49] Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
    Elliott, Perry
    Drachman, Brian M.
    Gottlieb, Stephen S.
    Hoffman, James E.
    Hummel, Scott L.
    Lenihan, Daniel J.
    Ebede, Ben
    Gundapaneni, Balarama
    Li, Benjamin
    Sultan, Marla B.
    Shah, Sanjiv J.
    CIRCULATION-HEART FAILURE, 2022, 15 (01) : E008193
  • [50] Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy
    Damy, T.
    Elliott, P.
    Gundapaneni, B.
    Tai, S. See
    Sultan, M. B.
    Drachman, B. M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2142 - 2142